Can Sodium‐Glucose Co‐Transporter‐2 Inhibitors Improve Sleep Quality, Anxiety, and Quality of Life in Patients With Heart Failure?
SGLT2 inhibitor use was associated with improved SQ and reduced anxiety in patients with HF, suggesting symptom-related benefits beyond cardiovascular effects.
Authors
- Pelin Aladağ (ORCID: https://orcid.org/0000-0003-4077-8012)
- Naile Eriş Güdül (ORCID: https://orcid.org/0000-0003-4102-081X)
- Ahmet Furkan Süner (ORCID: https://orcid.org/0000-0003-1383-3215)
- Ahmet Avcı (ORCID: https://orcid.org/0000-0002-8510-572X)
- İlke Erbay (ORCID: https://orcid.org/0000-0002-6817-4686)
- Umit Karacar (ORCID: https://orcid.org/0009-0003-4242-8013)
Institutions
- Zonguldak Bülent Ecevit University (TR)
Publication Details
- Journal
- Clinical Cardiology
- Published
- 2025-08-01
- DOI
- https://doi.org/10.1002/clc.70190
- Citations
- 3
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 3.88